The University of Alabama at Birmingham (UAB) Kidney-Pancreas Transplant faculty have busy elective dialysis access practices. Almost 1,000 operative cases are performed each year. A strong emphasis ...

Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines. Basilic ...

Please provide your email address to receive an email when new articles are posted on . Before the pandemic, 34.5% of patients with disabilities and end-stage kidney disease transitioned to home ...

Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.

Patients with kidney failure must often have hemodialysis one or more times each week to assist their kidneys in filtering waste products out of their blood streams. The dialysis filtering process ...

Employment rates for patients with end-stage kidney disease were higher for those with access to home hemodialysis or evening ...

A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...

The LifeSite Hemodialysis System (Vasca, Inc., Tewksbury, MA, USA)is totally subcutaneous, incorporating two silicone catheters positioned in the central venous system and connected to a stainless ...

Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This ...

Explore why peritoneal dialysis, a home-based treatment, offers a better quality of life for kidney failure patients despite ...

Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...